Similar Articles
2101 Postoperative adjuvant antiviral therapy for hepatitis B/C virus-related hepatocellular carcinoma: A meta-analysis
2102 CYP2E1 PstI/RsaI polymorphism and colorectal cancer risk: A meta-analysis
2103 Clinical features of hepatitis B virus-related hepatocellular carcinoma
2104 High-dose vs low-dose proton pump inhibitors for upper gastrointestinal bleeding: A meta-analysis
2105 Hepatocellular carcinoma in thalassemia: A critical review
2106 Systematic review and meta-analysis of Saccharomyces boulardii in adult patients
2107 Insulin resistance is associated with hepatocellular carcinoma in chronic hepatitis C infection
2108 Prophylaxis for venous thromboembolism after resection of hepatocellular carcinoma on cirrhosis: Is it necessary?
2109 Peroxisome proliferator-activated receptor-γ 34C>G polymorphism and colorectal cancer risk: A meta-analysis
2110 Late retroperitoneal recurrence of hepatocellular carcinoma 12 years after initial diagnosis
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA